drugset / Trial / NCT05397262

Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

NCT05397262

NaSingle-groupOpen-labelTreatment

Summary

Analysis of the efficacy and the compatibility of deep regional hyperthermia in combination with radiotherapy and chemoradiotherapy in bladder cancer

Timeline

Start
2017-03-29
Primary completion
2098-12-31
Completion
2099-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 20 mg/m2
Background fluorouracil Small molecule 600 mg/m2